Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
Bacterial vaginosis is a mild infection of the vagina caused by bacteria. This is usually a mild problem that may go away on its own in a few days. But sometimes can lead to more serious problems. Certain things make it more likely to happen.
The few of them are having more than one sex partner or have a new sex partner, smoke and douche. Many things can cause abnormal vaginal discharge, including some sexually transmitted infections (STIs). Doctors diagnose bacterial vaginosis by asking about the symptoms, doing a pelvic exam, and taking a sample of the vaginal discharge. The sample can be tested to find out if you have bacterial vaginosis. Bacterial vaginosis usually does not cause other health problems. But in some cases it can lead to serious problems.
During pregnancies, it increases the risk of miscarriage, early (preterm) delivery, and uterine infection after pregnancy.
Bacterial vaginosis is the most common cause of vaginal symptoms among women, but it is not clear what role sexual activity plays in the development of BV. The prevalence in the United States is estimated to be 21.2 million (29.2%) among women ages 14–49. Though the awareness has seen among the women’s in developed countries, most of the people from underdeveloped and developing countries are less concerned about this problem. Due to negligence, the state of disease becomes more and serious. In order to create awareness globally, pharma and medical authorities are conducting symposiums and workshops in a regular pace in a year. Many biotech sectors and clinical groups are now engaged in the awareness program to teach people how to recognize bacterial vaginosis and process of avoiding it care during this infection.
Most of the pharma, as well as corporate giants with the culminating support of their research and development innovations, have been launched many effective medicines to help to get rid of this chronic infection. At present, the new antibiotics are welcomed by the people. Biotech sectors are investing in making effective drugs to treat and prevent these infections as well. For all these cooperative works, globally drug sale for this disease become more and creating a visible inflation in global market. Because of this global awareness, a direct impact has been seen in the global market for inflating the business value of the pharma as well as the corporate sectors. A huge growth and employment opportunity have also been observed in the drug marketing sectors in serving and product marketing for Bacterial vaginosis, antibiotics, and other allied treatment.
Increase in the business value for bacterial vaginosis and disease management by different pharma sectors have also inspired the young and energetic entrepreneur to invest in the pharma sector.
OMICS Group is one of the leading Open Access scientific publication group taking initiative and is committed to make genuine and reliable contributions to the world’s scientific community. OMICS Group Publication covers 300 leading edge peer reviewed Open Access journals and have organized over 300 International Conferences all over the world every year. OMICS Publishing Group journals have over 3 million readers and the success Pilar has lies in it’s strong editorial board which contains over 30,000 eminent personalities and so results in the rapid, quality and quick review processing. OMICS Group in it’s Conferences, will put the finest effort for making the perfect platform for global scientific networking as it brings together renowned speakers and scientists across the globe to a most exciting and memorable scientific event filled with much enlightening interactive and sessions, world class exhibitions and poster presentations and 1000 more <="" a="" style="box-sizing: border-box; font-family: Arial, Helvetica, sans-serif; font-size: 12px; color: rgb(0, 64, 128); text-decoration: none; font-weight: normal;">
Competitive conferences
Worldwide a number of genuine conferences have been scheduled and also being commenced at times to related to bacterial vaginosis and new treatments. These international conferences inviting medical practitioner, researchers, pharmaceutical and allied corporate sectors, public as well as govt. societies to take part for creating awareness about the contemporary development in bacterial vaginosis and management and prevention. One of such resembling conference, The Vaginal Microbiome and Bacterial Vaginosis, was being conducted by Genesis Biotechnology Group (GBG) in USA.
This page will be updated regularly.
This page was last updated on November 5, 2024
